Drug Profile
Plastoquinonyl decyl triphenylphosphonium - Mitotech
Alternative Names: Plastomitin; SkQ-1; SkQ1 eye drops; SkQ1 pill; VisomitinLatest Information Update: 28 Jan 2023
Price :
$50
*
At a glance
- Originator Mitotech
- Class Anti-inflammatories; Benzoquinones; Eye disorder therapies; Halogenated hydrocarbons; Organophosphorus compounds; Small molecules
- Mechanism of Action Antioxidants; Electron transport chain complex protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase III Dry eyes
- Phase II Leber's hereditary optic atrophy
- Phase I Dry age-related macular degeneration; Glaucoma
- No development reported Acute kidney injury; Barth syndrome; Inflammation; Multiple sclerosis; Neurodegenerative disorders; Uveitis; Wet age-related macular degeneration
Most Recent Events
- 28 Jan 2023 No recent reports of development identified for preclinical development in Acute kidney injury in USA (PO, Pill)
- 28 Jan 2022 No recent reports of development identified for phase-I development in Dry age-related macular degeneration in USA (Ophthalmic, Drops)
- 28 Jan 2022 No recent reports of development identified for phase-I development in Uveitis in USA (Ophthalmic, Drops)